{"id":"https://openalex.org/W2802762779","doi":null,"title":"Advances in melanoma immunotherapy","display_name":"Advances in melanoma immunotherapy","publication_year":2017,"publication_date":"2017-12-21","ids":{"openalex":"https://openalex.org/W2802762779","mag":"2802762779"},"language":"en","primary_location":{"id":"pmh:oai:hrcak.srce.hr:192125","doi":null,"is_oa":true,"landing_page_url":"http://hrcak.srce.hr/192125","pdf_url":"http://hrcak.srce.hr/192125","source":{"id":"https://openalex.org/S4306400677","display_name":"Hr\u010dak Portal of scientific journals of Croatia (University Computing Centre)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210104502","host_organization_name":"United Nations University","host_organization_lineage":["https://openalex.org/I4210104502"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Libri Oncologici : Croatian Journal of Oncology","raw_type":"info:eu-repo/semantics/article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://hrcak.srce.hr/192125","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067613375","display_name":"Nina Dabeli\u0107","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138937732","display_name":"University Hospital Centre Zagreb","ror":"https://ror.org/00r9vb833","country_code":"HR","type":"healthcare","lineage":["https://openalex.org/I138937732"]},{"id":"https://openalex.org/I4210123681","display_name":"Sisters of Charity Hospital","ror":"https://ror.org/024a8dx81","country_code":"HR","type":"healthcare","lineage":["https://openalex.org/I4210123681"]},{"id":"https://openalex.org/I4210128318","display_name":"Ministry of Health","ror":"https://ror.org/03x4sv346","country_code":"HR","type":"government","lineage":["https://openalex.org/I4210128318"]}],"countries":["HR"],"is_corresponding":false,"raw_author_name":"Dabeli\u0107, Nina","raw_affiliation_strings":["Department of On- cology and Nuclear Medicine , Sestre milosrdnice Univer- sity Hospital Center , Vinogradska 29 , 10000 Zagreb , Croatia","Department of Oncology and Radiotherapy, Reff eral Center for Melanoma of Ministry of Health of Republic of Croatia, Sestre milosrdnice University Hospital Center, Zagreb, Croatia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of On- cology and Nuclear Medicine , Sestre milosrdnice Univer- sity Hospital Center , Vinogradska 29 , 10000 Zagreb , Croatia","institution_ids":["https://openalex.org/I138937732","https://openalex.org/I4210123681"]},{"raw_affiliation_string":"Department of Oncology and Radiotherapy, Reff eral Center for Melanoma of Ministry of Health of Republic of Croatia, Sestre milosrdnice University Hospital Center, Zagreb, Croatia","institution_ids":["https://openalex.org/I138937732","https://openalex.org/I4210123681","https://openalex.org/I4210128318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110650663","display_name":"Jasmina Mari\u0107 Brozi\u0107","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138937732","display_name":"University Hospital Centre Zagreb","ror":"https://ror.org/00r9vb833","country_code":"HR","type":"healthcare","lineage":["https://openalex.org/I138937732"]},{"id":"https://openalex.org/I4210123681","display_name":"Sisters of Charity Hospital","ror":"https://ror.org/024a8dx81","country_code":"HR","type":"healthcare","lineage":["https://openalex.org/I4210123681"]},{"id":"https://openalex.org/I4210128318","display_name":"Ministry of Health","ror":"https://ror.org/03x4sv346","country_code":"HR","type":"government","lineage":["https://openalex.org/I4210128318"]}],"countries":["HR"],"is_corresponding":false,"raw_author_name":"Mari\u0107 Brozi\u0107, Jasmina","raw_affiliation_strings":["Department of Oncology and Radiotherapy, Reff eral Center for Melanoma of Ministry of Health of Republic of Croatia, Sestre milosrdnice University Hospital Center, Zagreb, Croatia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology and Radiotherapy, Reff eral Center for Melanoma of Ministry of Health of Republic of Croatia, Sestre milosrdnice University Hospital Center, Zagreb, Croatia","institution_ids":["https://openalex.org/I138937732","https://openalex.org/I4210123681","https://openalex.org/I4210128318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008878011","display_name":"Nikola \u0110akovi\u0107","orcid":"https://orcid.org/0000-0001-6879-7739","observed_orcids":["https://orcid.org/0000-0001-6879-7739"]},"institutions":[{"id":"https://openalex.org/I138937732","display_name":"University Hospital Centre Zagreb","ror":"https://ror.org/00r9vb833","country_code":"HR","type":"healthcare","lineage":["https://openalex.org/I138937732"]},{"id":"https://openalex.org/I4210123681","display_name":"Sisters of Charity Hospital","ror":"https://ror.org/024a8dx81","country_code":"HR","type":"healthcare","lineage":["https://openalex.org/I4210123681"]},{"id":"https://openalex.org/I4210128318","display_name":"Ministry of Health","ror":"https://ror.org/03x4sv346","country_code":"HR","type":"government","lineage":["https://openalex.org/I4210128318"]}],"countries":["HR"],"is_corresponding":false,"raw_author_name":"\u0110akovi\u0107, Nikola","raw_affiliation_strings":["Department of Oncology and Radiotherapy, Reff eral Center for Melanoma of Ministry of Health of Republic of Croatia, Sestre milosrdnice University Hospital Center, Zagreb, Croatia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology and Radiotherapy, Reff eral Center for Melanoma of Ministry of Health of Republic of Croatia, Sestre milosrdnice University Hospital Center, Zagreb, Croatia","institution_ids":["https://openalex.org/I138937732","https://openalex.org/I4210123681","https://openalex.org/I4210128318"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085773867","display_name":"Ante Bolan\u010da","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138937732","display_name":"University Hospital Centre Zagreb","ror":"https://ror.org/00r9vb833","country_code":"HR","type":"healthcare","lineage":["https://openalex.org/I138937732"]},{"id":"https://openalex.org/I4210123681","display_name":"Sisters of Charity Hospital","ror":"https://ror.org/024a8dx81","country_code":"HR","type":"healthcare","lineage":["https://openalex.org/I4210123681"]},{"id":"https://openalex.org/I4210128318","display_name":"Ministry of Health","ror":"https://ror.org/03x4sv346","country_code":"HR","type":"government","lineage":["https://openalex.org/I4210128318"]}],"countries":["HR"],"is_corresponding":false,"raw_author_name":"Bolan\u010da, Ante","raw_affiliation_strings":["Department of Oncology and Radiotherapy, Reff eral Center for Melanoma of Ministry of Health of Republic of Croatia, Sestre milosrdnice University Hospital Center, Zagreb, Croatia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology and Radiotherapy, Reff eral Center for Melanoma of Ministry of Health of Republic of Croatia, Sestre milosrdnice University Hospital Center, Zagreb, Croatia","institution_ids":["https://openalex.org/I138937732","https://openalex.org/I4210123681","https://openalex.org/I4210128318"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1309,"has_fulltext":true,"cited_by_count":2,"citation_normalized_percentile":{"value":0.48988748,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melanoma","display_name":"melanoma","score":0.8740000128746033},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.9179999828338623},{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9959999918937683},{"id":"https://openalex.org/keywords/ctla-4-blockade","display_name":"CTLA-4 blockade","score":0.9300000071525574},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9359999895095825},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":1.0},{"id":"https://openalex.org/keywords/ipilimumab","display_name":"ipilimumab","score":1.0},{"id":"https://openalex.org/keywords/talimogene-laherparepvec","display_name":"talimogene laherparepvec","score":0.8930000066757202},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.6159999966621399},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.6589999794960022},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6710000038146973}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6086649298667908},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5320122241973877},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4767002761363983},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.34346258640289307},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.237164705991745},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.19866257905960083},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.19182008504867554}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:hrcak.srce.hr:192125","doi":null,"is_oa":true,"landing_page_url":"http://hrcak.srce.hr/192125","pdf_url":"http://hrcak.srce.hr/192125","source":{"id":"https://openalex.org/S4306400677","display_name":"Hr\u010dak Portal of scientific journals of Croatia (University Computing Centre)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210104502","host_organization_name":"United Nations University","host_organization_lineage":["https://openalex.org/I4210104502"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Libri Oncologici : Croatian Journal of Oncology","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:hrcak.srce.hr:192125","doi":null,"is_oa":true,"landing_page_url":"http://hrcak.srce.hr/192125","pdf_url":"http://hrcak.srce.hr/192125","source":{"id":"https://openalex.org/S4306400677","display_name":"Hr\u010dak Portal of scientific journals of Croatia (University Computing Centre)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210104502","host_organization_name":"United Nations University","host_organization_lineage":["https://openalex.org/I4210104502"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Libri Oncologici : Croatian Journal of Oncology","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2802762779.pdf","grobid_xml":"https://content.openalex.org/works/W2802762779.grobid-xml"},"referenced_works_count":21,"referenced_works":["https://openalex.org/W1828940258","https://openalex.org/W1950572133","https://openalex.org/W2031188948","https://openalex.org/W2070825440","https://openalex.org/W2097995306","https://openalex.org/W2109274792","https://openalex.org/W2112121482","https://openalex.org/W2118449798","https://openalex.org/W2123363005","https://openalex.org/W2128035403","https://openalex.org/W2143923888","https://openalex.org/W2152061559","https://openalex.org/W2152897456","https://openalex.org/W2166662937","https://openalex.org/W2167925208","https://openalex.org/W2338494814","https://openalex.org/W2482348008","https://openalex.org/W2492926859","https://openalex.org/W2553340100","https://openalex.org/W2752227448","https://openalex.org/W2890815045"],"related_works":["https://openalex.org/W2518538521","https://openalex.org/W2116150249","https://openalex.org/W2479828838","https://openalex.org/W2894682738","https://openalex.org/W2190137944","https://openalex.org/W3016779370","https://openalex.org/W2190782500","https://openalex.org/W2895244345","https://openalex.org/W4368375547","https://openalex.org/W2263279668"],"abstract_inverted_index":{"Melanoma":[0],"is":[1,11],"considered":[2],"to":[3,67,113],"be":[4],"the":[5,41,46,71,78,88,97,143],"most":[6],"immunogenic":[7],"malignant":[8],"tumour.This":[9],"fact":[10],"recognized":[12],"for":[13,27,32,146],"many":[14],"years,":[15,44,117],"and":[16,55,118,132,134],"certain":[17],"forms":[18],"of":[19,49,70,101,122],"immunotherapy":[20,61],"have":[21,37,91,136],"been":[22,137],"used":[23],"in":[24,40,87,139],"melanoma":[25,36,60,105,148],"therapy":[26,129],"a":[28],"considerable":[29],"time.Treatment":[30],"options":[31,90],"patients":[33,102],"with":[34,45,96,103,130],"metastatic":[35,104,147],"changed":[38],"dramatically":[39,92],"past":[42],"5":[43],"FDA":[47],"approval":[48],"eight":[50],"new":[51],"therapeutic":[52],"agents":[53],"(immunotherapies":[54],"targeted":[56],"therapies).During":[57],"this":[58],"period,":[59],"has":[62],"transitioned":[63],"from":[64,107],"cytokine-based":[65],"treatment":[66,89,145],"antibody-mediated":[68],"blockade":[69],"cytotoxic":[72],"Tlymphocyteassociated":[73],"antigen4":[74],"(CTLA4)":[75],"and,":[76],"recently,":[77],"programmed":[79],"cell-death":[80],"protein":[81],"1":[82],"(PD1)":[83],"immune":[84],"checkpoints.These":[85],"changes":[86],"improved":[93],"patient":[94],"outcomes,":[95],"median":[98],"overall":[99],"survival":[100],"increasing":[106],"approximately":[108],"9":[109],"months":[110],"before":[111],"2011":[112],"at":[114],"least":[115],"2":[116],"probably":[119],"longer.Various":[120],"types":[121],"immunotherapy,":[123],"like":[124],"pembrolizumab,":[125],"nivolumab,":[126],"ipilimumab,":[127,133],"combined":[128],"nivolumab":[131],"T-VEC,":[135],"established":[138],"recent":[140],"years":[141],"as":[142],"standard-of-care":[144],"patients.":[149]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2018-05-17T00:00:00"}